close to approving another new drug for obesity
The FDA is getting close to approving another new drug for obesity...Meridia (sibutramine) from Knoll.
Meridia is a serotonin AND norepinephrine reuptake inhibitor. It's in the same class as the antidepressant Effexor (venlafaxine).
In fact, Meridia was originally being developed as an antidepressant. The manufacturer switched gears when they noticed that it causes weight loss. The weight loss market is a lot less crowded than the antidepressant market.